“…Agent-based simulation has been applied across domains, such as biology, health, economics and urban sciences. However, engineering robust, efficient, maintainable, and reliable agent-based simulations is challenging. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Though there are challenges in the designing and implementation of MEAs, close networking, improved human capital development especially in the area of health technology assessment and health economics would be able to close the gap in the implementation.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This paper provides both the context for and contributing factors that make the proposing of such an objective Prescription Index an interesting thing to consider when discussing Health Economics in P&O.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Evaluating efficacy and real-world effectiveness for novel therapies targeting rare mutations or patient subpopulations with unmet needs is a growing challenge in health economics and outcomes research (HEOR). In these settings it may be difficult to recruit enough patients to run adequately powered randomized clinical trials, resulting in greater reliance on single-arm trials or basket trial designs. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The other four studies presented VE data against laboratory-confirmed influenza. Three health economics studies focusing on a pediatric population also found the use of QIVc to be cost-effective or cost-saving. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Population health measurement potentially bridges a range of currently disjoint fields of inquiry relating to health: biology, demography, epidemiology, health economics, and broader social science disciplines relevant to assessment of health determinants, health state valuations and health inequalities. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS AND FINDINGS: Studies were identified from the following bibliographic databases: MEDLINE (Ovid), EMBASE (Ovid), Cochrane Library (Wiley's internet version), NHS EED and DARE Office of Health Economics HEED. The searches were conducted in November 2009. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…There is currently only limited evidence regarding the health economics of lenalidomide. ROLE IN THERAPY: The encouraging results obtained with lenalidomide alone and in combination with dexamethasone in patients with relapsed or refractory MM have led to its adoption as a recommended therapy in patients who have received at least one prior treatment. …”
Enlace del recurso
Enlace del recurso

“…The Nouna HDSS has been used as a sampling frame for numerous studies in the fields of clinical research, epidemiology, health economics, and health systems research. In this paper we review some of the main findings, and we describe the effects that almost 20 years of health research activities have shown in the population in general and in terms of the perception, economic implications, and other indicators. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We then used the model to estimate the likely epidemiological and clinical outcomes without NSPs and conducted a health economics analysis to determine the cost-effectiveness of the program. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The recent merging of health economics and nutritional sciences to form the nascent discipline of nutrition economics aims to assess the impact of diet on health and disease prevention, and to evaluate options for changing dietary choices, while incorporating an understanding of the immediate impacts and downstream consequences. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Papers were excluded if they did not present cost calculations, therapeutic cost comparisons, or health economic endpoints. Results: Clinical outcomes and costs of SRS and SBRT were compared to other therapies for treatment of cancer in the brain, spine, lung, prostate, and pancreas. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Future planned analyses will address the onset and progression of microvascular triopathy, evidence-based screening for retinopathy and nephropathy, effects of glycemic variability and nonglycemic risk factors on outcomes, long-term impact of intensive therapy on cognitive decline, and health economics. Three new proposed investigations include an examination of residual C-peptide secretion and its impact, prevalence of hearing impairment, and evaluation of gastrointestinal dysfunction. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND/AIMS: The quality-adjusted life-year (QALY) and health state utility values (HSUVs) are major quality of life scales that are used for the analyses of health economics of diseases such as Alzheimer's disease (AD). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…It can have a negative impact on both quality of life and health economics. Severe oral mucositis can contribute to hospitalization, need for narcotic analgesics, total parentral nutrition, suboptimal delivery of anti-neoplastic treatment, and morbidity and mortality. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…It provides a brief overview of basic health economics principles and frameworks and discusses some methodological issues and challenges in conducting cost-effectiveness analysis of eHealth interventions. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Cultural attitudes towards death, medical education and culture, health economics and the societal role of family were commonly identified as factors influencing perception of DNACPR decisions. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Excess body weight has become a major public health problem worldwide, and the burden of overweight and obesity was calculated in this work from a health economics perspective. OBJECTIVE: To estimate the burden of disease attributable to overweight and obesity among males and females aged 20 years and older using years of life lost (YLL) and age-standardized YLL rates (ASYLL), and to rank the leading causes of premature death. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Our findings provide an empirical basis for further study on methods, research prioritization, and capacity development in health economic evaluation.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso